BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
477.507017
NSE Symbol
NATCOPHARM
Divident Yield %
0.6
Market Cap
(Rs In Cr.)
14,796
P/E (TTM)
16.59
EPS (TTM)
49.8
Face Value
(Rs)
2
Back
Natco Pharma consolidated net profit declines 34.11% in the March 2026 quarter
30-May-26   Hrs IST

Net profit of Natco Pharma declined 34.11% to Rs 267.90 crore in the quarter ended March 2026 as against Rs 406.60 crore during the previous quarter ended March 2025. Sales declined 39.47% to Rs 739.10 crore in the quarter ended March 2026 as against Rs 1221.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 24.76% to Rs 1418.50 crore in the year ended March 2026 as against Rs 1885.40 crore during the previous year ended March 2025. Sales declined 7.93% to Rs 4078.30 crore in the year ended March 2026 as against Rs 4429.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales739.101221.00 -39 4078.304429.50 -8
OPM %17.2644.89 -35.2249.58 -
PBDT194.50604.20 -68 1697.402526.60 -33
PBT144.10505.90 -72 1490.802291.40 -35
NP267.90406.60 -34 1418.501885.40 -25

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)